SZSE Ticker: 300639

Guangdong Hybribio Biotech Co., Ltd.

广东凯普生物科技股份有限公司

凯普生物

HYBRIBIO BIOTECH

Listing Date: 2017-04-12

Board: GEM

Industry Classification: Manufacturing

Central Bureau Observation of Nucleic Acid Testing①｜The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

Post date May 12, 2022 — 13:32 Post Lock

[Earlier to know] National regular meeting: Allocate another 50 billion yuan in renewable energy subsidies to central power generation companies; U.S. stocks closed down

Post date May 12, 2022 — 09:51 Post Lock

Good News Express: The National Standing Committee requires fiscal and monetary policies to be employment-oriented, central power generation companies will be allocated 50 billion yuan in renewable energy subsidies, Shenglong shares received a notification from Sichuan Ideal

Post date May 12, 2022 — 08:55 Post Lock

Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com

Post date May 12, 2022 — 07:15 Post Lock

The Latest Announcement of Kaipu Bio: It is planned to invest 1.512 billion yuan in the construction of Kaipu Medical Science Park_Stock News_Market Gold Online

Post date May 11, 2022 — 23:22 Post Lock

Top 10 major announcements of listed companies on the evening of May 11

Post date May 11, 2022 — 23:10 Post Lock

Kaipu Bio (300639): Plans to invest in the construction of Kaipu Medical Science Park- CFi.CN Zhongcai Network

Post date May 11, 2022 — 22:42 Post Lock

Kaipu Biotechnology (300639): Resolution of the 30th meeting of the 4th Supervisory Committee- CFi.CN Zhongcai Network

Post date May 11, 2022 — 22:42 Post Lock

Kaipu Bio (300639.SZ) plans to invest 1.512 billion yuan to build Kaipu Medical Science Park in Chao'an District, Chaozhou City_Individual Stock Information_Market Gold Online

Post date May 11, 2022 — 22:37 Post Lock

Kaipu Bio (300639.SZ): Plans to invest 1.512 billion yuan to build Kaipu Medical Science Park_Individual Stock Information_Market Gold Online

Post date May 11, 2022 — 22:27 Post Lock

Highlights of the announcement on the evening of May 11: PICC’s three subsidiaries’ original insurance premium income totaled 276.159 billion yuan in the first four months

Post date May 11, 2022 — 22:24 Post Lock

Kaipu Biotechnology plans to invest 1.512 billion yuan to build Kaipu Medical Science Park in Chao'an District, Chaozhou City

Post date May 11, 2022 — 22:23 Post Lock

Kaipu Bio: It is planned to invest 1.512 billion yuan in the construction of Kaipu Medical Science Park_ Oriental Fortune Net

Post date May 11, 2022 — 22:23 Post Lock

Kaipu Bio (300639.SZ) plans to invest 1.512 billion yuan to build Kaipu Medical Science Park in Chao'an District, Chaozhou City

Post date May 11, 2022 — 22:21 Post Lock

Kaipu Bio (300639.SZ) plans to invest 1.512 billion yuan to build Kaipu Medical Science Park in Chao'an District, Chaozhou City

Post date May 11, 2022 — 22:21 Post Lock

Kaipu Bio: It is planned to invest 1.512 billion yuan to build Kaipu Medical Science Park

Post date May 11, 2022 — 22:20 Post Lock

Kaipu Bio: Plans to invest 1.512 billion yuan to build Kaipu Medical Science Park_ Securities Times Network

Post date May 11, 2022 — 22:20 Post Lock

3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews

Post date May 11, 2022 — 20:54 Post Lock

Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews

Post date May 10, 2022 — 19:03 Post Lock

The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm

Post date May 10, 2022 — 18:49 Post Lock

Want to see more data? Registered subscribers can see all the data.